Olainfarm has Acquired 47.5% of Shares in Silvanols

on May 2, 2013

JSC Olainfarm has acquired 47.5% shares in the third largest Latvian pharmaceutical manufacturer Silvanols Ltd.  It is expected that another 20% or more will be acquired in the nearest future. This acquisition will allow both companies to expand their product groups and portfolio and enter and expand into new markets.

“Over last several years Olainfarm has made significant investments in expansion of its product portfolio, sales markets and business segments. Acquisition of Silvanols is yet another step towards vision of Olainfarm to become a leading producer of finished dosage forms and chemical products in the Baltics, whose products is well known and available throughout the world.  We see a very good opportunity to increase the speed of growth by merging expertise, experience and export potential of the two companies and by creating and developing joint projects,says Salvis Lapins, Member of the Board of JSC Olainfarm.

Co-owner and the Board Member of Silvanols Ltd. Ieva Leimane notes that this is a logical next step in company’s development.  Having a new shareholder in Silvanols will help the company to develop faster, improve its logistical systems, and, what is particularly important, will provide new export markets for the company. I am sure and our recent experience confirms it, that our products are veru compatitive not only in Latvia but also abroad.”

Chairman of the Board of Silvanols Ltd. Viesturs Gurtlavs emphasizes that “changes that have occurred to list of company’s shareholders will facilitate inflow of new knowledge and experience into Silvanols which will be yet another boost for competitiveness of the company internationally and domestically”.

After the transaction Board Member of Olainfarm Mr. Salvis Lapins has also become a Member of Silvanols’ Board.

Sales of Silvanols Ltd. in 2012 were 1.993 million lats and the company made a net profit of 136 thousand lats.

Consolidated profit and loss statement of JSC Olainfarm for 2012 shows that the concern has set yet another profit record as it has made a net profit of 9.75 million lats (13.88 milion euro).  This represents an increase by 41% compared to 2011, when profit of JSC Olainfarm was 6.91 million lats (9.84 million euro).


JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.


Silvanols Ltd. is one of the most rapidly growing Latvian producers of medicines. In its operations Silvanols uses modern internationally applied technologies. Products portfolio of the company consists of unique set of original products, including over-the-counter medicines, medical devices and food supplements, in total more than 70 different original products. Company is particularly proud of their original products, including market leader Faringo Spray®, anti-rhinitis gel Rinogēls® and sedative mixture of 7 different herbs  Relaxen®. Currently products of the company are being exported to Lithuania, Estonia, Azerbaijan, Romania, Czech Republic, Hungary, Belarus, Kazakhstan, Slovakia and Armenia.


Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873

Olainfarm has Acquired 47.5% of Shares in Silvanols